Patents Examined by Alexander M Eisenberg
  • Patent number: 11123573
    Abstract: The present invention refers to a skin or hair treatment device for emitting intense light radiation with an integrated sensor. The device has a housing; a treatment light source, wherein the treatment light source comprises an array of a plurality of light emitting elements arranged on a substrate; a sensor system, the sensor system has at least one sensing light source for emitting sensing light and at least one light sensor for detecting the sensing light, wherein the at least one sensing light source and the at least one light sensor are directed towards a device treatment window; and a control circuit having a processor.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: September 21, 2021
    Assignee: Braun GMBH
    Inventors: Frank Beerwerth, Uwe Bielfeldt, Dalibor Dadic, Felix Heinemann
  • Patent number: 11110264
    Abstract: The present invention provides an intravascular blood pump comprising an expandable and collapsible region distal to a pump assembly. In some embodiments, the expandable and collapsible region may comprise expandable and collapsible proximal and/or distal transition sections adjacent a central expandable and collapsible region. Support structure, e.g., an expandable and collapsible stent may comprise at least a part of the expandable and collapsible region. In some embodiments, a distal portion of the housing comprises the expandable and collapsible region, wherein an inversion of the distal housing results in a collapsed configuration and eversion of the distal housing results in an expanded configuration.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: September 7, 2021
    Assignee: Cardiovascular Systems, Inc.
    Inventors: Matthew D. Cambronne, Joseph P. Higgins, Benjamin D. Haselman, Tristan A. Van de Moortele, Matthew W. Tilstra, Jeffrey R. Stone
  • Patent number: 11071872
    Abstract: An implantable system includes a first leadless pacemaker (LP1) implanted in or on a first chamber of a heart and a second leadless pacemaker (LP2) implanted in or on a second chamber of the heart. The LP1 is configured to time delivery of one or more pacing pulses delivered to the first chamber of the heart based on timing of cardiac activity associated with the second chamber of the heart detected by the LP1 itself. The LP1 is also configured to transmit implant-to-implant (i2i) messages to the LP2. The LP2 is configured to time delivery of one or more pacing pulses delivered to the second chamber of the heart based on timing of cardiac activity associated with the second chamber of the heart as determined based on one or more i2i messages received by the LP2 from the LP1.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: July 27, 2021
    Assignee: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Matthew G. Fishler
  • Patent number: 11065445
    Abstract: Closed-loop transcranial stimulation and monitoring is disclosed that includes generating a stimulation signal having a set of first oscillation parameters; applying the stimulation signal transcranially to a patient; monitoring the stimulation signal as applied to the patient; receiving a brain activity signal from the patient; generating a feedback signal based on the monitored stimulation signal as applied to the patient; and generating a modified activity signal by subtracting the feedback signal from the brain activity signal; determining one or more second oscillation parameters of the modified activity signal; and adjusting the set of first oscillation parameters of the stimulation signal based on the one or more second oscillation parameters of the modified activity signal. Closed-loop transcranial stimulation and monitoring is also disclosed in which the patient is engaged in a cognitive task.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: July 20, 2021
    Assignee: Monash University
    Inventors: Paul B Fitzgerald, Caley M. Sullivan, Richard H. Thomson
  • Patent number: 11045144
    Abstract: An auscultatory sound signal acquired by a recording module is coupled through a high-pass filter having a cut-off frequency in the range of 3 to 15 Hz and subsequently filtered with a low-pass filter, and optionally subject to variable-gain amplification under external control—via a USB or wireless interface—of an associated docking system, responsive to the resulting processed auscultatory sound signal. A sound generator in the docking system generates an associated test signal having an integral number of wavelengths for each of a plurality of frequencies. The test signal is applied to a corresponding auscultatory sound-or-vibration sensor to test the integrity thereof. Resulting sound signals recorded by the recording module are analyzed using a Fourier Transform to determine sensor integrity.
    Type: Grant
    Filed: October 21, 2018
    Date of Patent: June 29, 2021
    Assignee: AusculSciences, Inc.
    Inventors: Jun Zhou, Md Shahidul Islam, Jikang Zeng, Daniel Labonté, Simon Martin, Brady Laska, Sergey A. Telenkov
  • Patent number: 11039752
    Abstract: Non-invasive sensor apparatus and method for assessing cardiac performance. A wide variety of different sensor components can capture sensor readings relating to patient attributes. Those sensor readings can then be compared by a processor component to derive a cardiac performance indicator relating to the patient.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: June 22, 2021
    Assignee: Accu-Therm Systems, Inc.
    Inventor: William W. O'Neill
  • Patent number: 11013912
    Abstract: Medical device systems, methods, and algorithms are disclosed for providing complex stimulation waveforms. The waveforms may selectively modulate or activate specific neural targets or selected ratios of specific neural targets. Some of the waveforms include pre-pulse phases defined by parameters, the value of which changes during the pre-pulse phase. Also disclosed herein are graphical user interfaces (GUIs) that allow the selection of waveforms configured to selectively modulate or activate specific neural targets or selected ratios of the neural targets. Adjustable parameters of the waveforms are adjusted automatically based on selection of user-defined parameters.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: May 25, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, G. Karl Steinke, Richard Mustakos
  • Patent number: 10998101
    Abstract: A method includes capturing continuously vital signs and motion data from one or more sensors adapted to be coupled to a user; capturing food consumption of the user; predicting a predetermined health condition of the user based on the vital signs; generating a plan for the predetermined health condition; and prompting the user to execute the plan with a closed-loop feedback based on sensor data.
    Type: Grant
    Filed: December 15, 2019
    Date of Patent: May 4, 2021
    Inventors: Bao Tran, Ha Tran
  • Patent number: 10980477
    Abstract: A wearable device according to various embodiments may include a biometric sensor, an output device, and a processor operatively coupled with the biometric sensor and the output device, and configured to obtain food intake information of a user corresponding to the wearable device, to obtain biometric information of the user by using the biometric sensor, to identify a digestibility of the food of the user, based at least in part on a change of the biometric information corresponding to the food intake information, and to provide information of the digestibility, using the output device.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: April 20, 2021
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: So Hyun Chung, Gitae Mun, Jeong-Min Park, Seung-Eun Lee, Sun Ok Jung
  • Patent number: 10918302
    Abstract: There is provided a biological signal processing apparatus. The biological signal processing apparatus includes a biological signal extraction unit (2) configured to extract a biological signal from an electrocardiographic waveform measured by an electrocardiograph (1), an averaging processing unit (3) configured to calculate averaged data using time-series data of the biological signals extracted by the biological signal extraction unit (2), an abnormal value determination unit (4) configured to determine, for each data, whether the data of the biological signal extracted by the biological signal extraction unit (2) is appropriate, based on the averaged data calculated using the data of the biological signals that have occurred before the data, and an abnormal value processing unit (5) configured to perform one of deletion and interpolation of the data of the biological signal determined to be inappropriate by the abnormal value determination unit (4).
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: February 16, 2021
    Assignee: NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    Inventors: Nobuaki Matsuura, Takayuki Ogasawara, Kei Kuwabara
  • Patent number: 10905890
    Abstract: An energy harvester converts into electrical energy the external stresses applied to the implant at the heartbeat rhythm. This harvester comprises an inertial unit and a transducer delivering an electrical signal that is rectified and regulated for powering the implant and charging an energy storage component. The charge level of the energy storage component is compared with a lower threshold to detect an insufficient charge, and a dynamic charging control circuit modifies, as and whenever necessary, and if the current patient's state allows it, a stimulation parameter in a direction liable to increase in return the mean level of the mechanical energy that is produced and harvested.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: February 2, 2021
    Assignee: CAIRDAC
    Inventor: Jean-Luc Bonnet
  • Patent number: 10881303
    Abstract: Sympathetic vasomotor identification and quantification systems that provide ways to assess therapies, diseases, and conditions which affect sympathetic innervation and function are described. Because sympathetic vasomotion relies on intact, functional sympathetic nerves, some embodiments of the sympathetic vasomotor identification and quantification systems described herein include a signal processing functionality that establishes sympathetic vasomotor signatures through the collection of arterial blood pressure and blood flow signals.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: January 5, 2021
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Irving H. Zucker, Alicia Marie Schiller, Peter Ricci Pellegrino
  • Patent number: 10842559
    Abstract: System and method for locating and identifying nerves innervating the wall of arteries such as the renal artery are disclosed. The present invention identifies areas on vessel walls that are innervated with nerves; provides indication on whether energy is delivered accurately to a targeted nerve; and provides immediate post-procedural assessment of the effect of energy delivered to the nerve. The method includes at least the steps to evaluate a change in physiological parameters after energy is delivered to an arterial wall; and to determine the type of nerve that the energy was directed to (none, sympathetic or parasympathetic) based on the evaluated results. The system includes at least a device for delivering energy to the wall of blood vessel; sensors for detecting physiological signals from a subject; and indicators to display results obtained using this method. Also provided are catheters for performing the mapping and ablating functions.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: November 24, 2020
    Assignee: SYMAP MEDICAL (SUZHOU), LIMITED
    Inventor: Jie Wang